Surgical resection combined with systemic chemotherapy is the cornerstone of treatment for
patients with localized pancreatic cancer. Upfront surgery is considered suboptimal in cases …

Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic,
surgically unresectable disease. Although the goal of early detection of PDAC is laudable …

Most patients with pancreatic adenocarcinoma (PDAC) suffer cachexia; some do not. To
model heterogeneity, we used patient-derived orthotopic xenografts. These phenocopied …

It has frequently been shown that patients with cancer are one of the largest hospital patient
groups with a prevalence for malnutrition. Weight loss is a frequent manifestation of …

Background The optimal nutritional therapy in the field of pancreatic surgery is still debated.
Methods An international panel of recognized pancreatic surgeons and pancreatologists …

Further research is needed to compare different definitions of sarcopenic/dynapenic obesity
to clarify the relationship between obesity and the most important adverse outcomes in the …

Pancreatic cancer (PC) is an aggressive disease, with a growing incidence, and a poor
prognosis. Neoadjuvant treatments in PC are highly recommended in borderline resectable …

Opinion statement Sarcopenia is being consistently recognized as a condition not only
associated with the presence of a malignancy but also induced by the oncologic therapies …

Introduction Prehabilitation aims to improve fitness and outcomes of patients undergoing
major surgery. This systematic review aimed to appraise current available evidence …

Muscle wasting often occurs as a consequence of anticancer treatments and is indicative of
worse outcomes and poor quality of life in cancer patients. Accurate assessment of body …